News
Avacta Group PLC - Issue of Equity
RNS Number: 3083 K Avacta Group PLC 09 April 2018. Avacta Group plc, the developer of Affimer ® biotherapeutics and research reagents, announces that application has been made for 10,345 new ordinary shares of 10 p each to be admitted to trading on AIM on 16 April 2018.. Antibodies dominate markets worth in excess of $100 bn despite their shortcomings.
RNS Number: 3083 K Avacta Group PLC 09 April 2018. Avacta Group plc, the developer of Affimer ® biotherapeutics and research reagents, announces that application has been made for 10,345 new ordinary shares of 10 p each to be admitted to trading on AIM on 16 April 2018.. Antibodies dominate markets worth in excess of $100 bn despite their shortcomings.